Streptolysin O Rapidly Impairs Neutrophil Oxidative Burst and Antibacterial Responses to Group A Streptococcus

Group A Streptococcus (GAS) causes a wide range of human infections, ranging from simple pharyngitis to life-threatening necrotizing fasciitis and toxic shock syndrome. A globally disseminated clone of M1T1 GAS has been associated with an increase in severe, invasive GAS infections in recent decades. The secreted GAS pore-forming toxin streptolysin O (SLO), which induces eukaryotic cell lysis in a cholesterol-dependent manner, is highly upregulated in the GAS M1T1 clone during bloodstream dissemination. SLO is known to promote GAS resistance to phagocytic clearance by neutrophils, a critical first element of host defense against invasive bacterial infection. Here, we examine the role of SLO in modulating specific neutrophil functions during their early interaction with GAS. We find that SLO at subcytotoxic concentrations and early time points is necessary and sufficient to suppress neutrophil oxidative burst, in a manner reversed by free cholesterol and anti-SLO blocking antibodies. In addition, SLO at subcytotoxic concentrations blocked neutrophil degranulation, interleukin-8 secretion and responsiveness, and elaboration of DNA-based neutrophil extracellular traps, cumulatively supporting a key role for SLO in GAS resistance to immediate neutrophil killing. A non-toxic SLO derivate elicits protective immunity against lethal GAS challenge in a murine infection model. We conclude that SLO exerts a novel cytotoxic-independent function at early stages of invasive infections (<30 min), contributing to GAS escape from neutrophil clearance.

[1]  V. Nizet,et al.  Cationic antimicrobial peptide resistance mechanisms of streptococcal pathogens. , 2015, Biochimica et biophysica acta.

[2]  R. Olsen,et al.  A molecular trigger for intercontinental epidemics of group A Streptococcus. , 2015, The Journal of clinical investigation.

[3]  V. Nizet,et al.  Mechanisms of group A Streptococcus resistance to reactive oxygen species , 2015, FEMS microbiology reviews.

[4]  S. W. Long,et al.  Evolutionary pathway to increased virulence and epidemic group A Streptococcus disease derived from 3,615 genome sequences , 2014, Proceedings of the National Academy of Sciences.

[5]  Timothy C. Barnett,et al.  Disease Manifestations and Pathogenic Mechanisms of Group A Streptococcus , 2014, Clinical Microbiology Reviews.

[6]  M. Parker,et al.  Structural studies of Streptococcus pyogenes streptolysin O provide insights into the early steps of membrane penetration. , 2014, Journal of molecular biology.

[7]  Mengyao Liu,et al.  Neutrophils Select Hypervirulent CovRS Mutants of M1T1 Group A Streptococcus during Subcutaneous Infection of Mice , 2014, Infection and Immunity.

[8]  V. Nizet,et al.  IgG Protease Mac/IdeS Is Not Essential for Phagocyte Resistance or Mouse Virulence of M1T1 Group A Streptococcus , 2013, mBio.

[9]  Manisha Pandey,et al.  Strategies in the development of vaccines to prevent infections with group A streptococcus , 2013, Human vaccines & immunotherapeutics.

[10]  C. Garlanda,et al.  Neutrophils in innate and adaptive immunity , 2013, Seminars in Immunopathology.

[11]  G. Bensi,et al.  Targeted Amino Acid Substitutions Impair Streptolysin O Toxicity and Group A Streptococcus Virulence , 2013, mBio.

[12]  V. Nizet,et al.  Influences of Chloride and Hypochlorite on Neutrophil Extracellular Trap Formation , 2012, PloS one.

[13]  S. Grinstein,et al.  Listeriolysin O suppresses phospholipase C-mediated activation of the microbicidal NADPH oxidase to promote Listeria monocytogenes infection. , 2011, Cell host & microbe.

[14]  V. Nizet,et al.  Molecular insight into invasive group A streptococcal disease , 2011, Nature Reviews Microbiology.

[15]  M. Wessels,et al.  Streptolysin O Inhibits Clathrin-Dependent Internalization of Group A Streptococcus , 2011, mBio.

[16]  V. Nizet,et al.  Statins enhance formation of phagocyte extracellular traps. , 2010, Cell host & microbe.

[17]  M. Duchen,et al.  The large-conductance Ca2+-activated K+ channel is essential for innate immunity , 2010, Nature.

[18]  V. Nizet,et al.  Parameters Governing Invasive Disease Propensity of Non-M1 Serotype Group A Streptococci , 2010, Journal of Innate Immunity.

[19]  M. Caparon,et al.  Streptococcus pyogenes cytolysin‐mediated translocation does not require pore formation by streptolysin O , 2010, EMBO reports.

[20]  V. Nizet,et al.  Visualization and Functional Evaluation of Phagocyte Extracellular Traps , 2010 .

[21]  J. Carapetis,et al.  Global emm type distribution of group A streptococci: systematic review and implications for vaccine development. , 2009, The Lancet. Infectious diseases.

[22]  T. Cherian,et al.  Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates , 2009, The Lancet.

[23]  J. McCaffery,et al.  Mitofusins and OPA1 mediate sequential steps in mitochondrial membrane fusion. , 2009, Molecular biology of the cell.

[24]  V. Nizet,et al.  Streptolysin O Promotes Group A Streptococcus Immune Evasion by Accelerated Macrophage Apoptosis* , 2009, Journal of Biological Chemistry.

[25]  Haruo Watanabe,et al.  Incompetence of Neutrophils to Invasive Group A streptococcus Is Attributed to Induction of Plural Virulence Factors by Dysfunction of a Regulator , 2008, PloS one.

[26]  Ramy K. Aziz,et al.  Rise and Persistence of Global M1T1 Clone of Streptococcus pyogenes , 2008, Emerging infectious diseases.

[27]  Malak Kotb,et al.  DNase Sda1 provides selection pressure for a switch to invasive group A streptococcal infection , 2007, Nature Medicine.

[28]  V. Nizet,et al.  How group A Streptococcus circumvents host phagocyte defenses. , 2007, Future microbiology.

[29]  V. Wahn,et al.  Novel cell death program leads to neutrophil extracellular traps. , 2007, The Journal of cell biology.

[30]  Carl Nathan,et al.  Neutrophils and immunity: challenges and opportunities , 2006, Nature Reviews Immunology.

[31]  Ramy K. Aziz,et al.  DNase Expression Allows the Pathogen Group A Streptococcus to Escape Killing in Neutrophil Extracellular Traps , 2006, Current Biology.

[32]  Edward A Graviss,et al.  Genome-Wide Analysis of Group A Streptococci Reveals a Mutation That Modulates Global Phenotype and Disease Specificity , 2006, PLoS pathogens.

[33]  J. Carapetis,et al.  The global burden of group A streptococcal diseases. , 2005, The Lancet. Infectious diseases.

[34]  V. Nizet,et al.  d-Alanylation of Teichoic Acids Promotes Group A Streptococcus Antimicrobial Peptide Resistance, Neutrophil Survival, and Epithelial Cell Invasion , 2005, Journal of bacteriology.

[35]  R. Tweten,et al.  Cholesterol-Dependent Cytolysins, a Family of Versatile Pore-Forming Toxins , 2005, Infection and Immunity.

[36]  J. Musser,et al.  Evolutionary origin and emergence of a highly successful clone of serotype M1 group a Streptococcus involved multiple horizontal gene transfer events. , 2005, The Journal of infectious diseases.

[37]  Adeline R. Whitney,et al.  Extracellular deoxyribonuclease made by group A Streptococcus assists pathogenesis by enhancing evasion of the innate immune response. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[38]  A. Zychlinsky,et al.  Neutrophil Extracellular Traps Kill Bacteria , 2004, Science.

[39]  M. Duchen,et al.  The large-conductance Ca2+-activated K+ channel is essential for innate immunity , 2004, Nature.

[40]  Adeline R. Whitney,et al.  Bacterial pathogens modulate an apoptosis differentiation program in human neutrophils , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[41]  M. Wessels,et al.  Cytotoxic Effects of Streptolysin O and Streptolysin S Enhance the Virulence of Poorly Encapsulated Group A Streptococci , 2003, Infection and Immunity.

[42]  Giorgio Gabella,et al.  Killing activity of neutrophils is mediated through activation of proteases by K+ flux , 2002, Nature.

[43]  J. Musser,et al.  Evasion of human innate and acquired immunity by a bacterial homolog of CD11b that inhibits opsonophagocytosis , 2001, Nature Medicine.

[44]  B. Limbago,et al.  Role of Streptolysin O in a Mouse Model of Invasive Group A Streptococcal Disease , 2000, Infection and Immunity.

[45]  Malak Kotb,et al.  Genetic Relatedness and Superantigen Expression in Group A Streptococcus Serotype M1 Isolates from Patients with Severe and Nonsevere Invasive Diseases , 2000, Infection and Immunity.

[46]  A. Conde.  Staphylococcus aureus infections. , 1998, The New England journal of medicine.

[47]  M. Wessels,et al.  Relative contributions of hyaluronic acid capsule and M protein to virulence in a mucoid strain of the group A Streptococcus , 1997, Infection and immunity.

[48]  M. Wessels,et al.  Hyaluronate capsule and surface M protein in resistance to opsonization of group A streptococci , 1996, Infection and immunity.

[49]  J. Tait,et al.  Challenges and opportunities. , 1996, Journal of psychiatric and mental health nursing.

[50]  M. Baggiolini,et al.  Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. , 1989, The Journal of clinical investigation.

[51]  J. Hancock,et al.  The inhibition by diphenyleneiodonium and its analogues of superoxide generation by macrophages. , 1987, The Biochemical journal.

[52]  I. Ginsburg,et al.  Oxygen-Stable Hemolysins of Group A Streptococci VIII. Leukotoxic and Antiphagocytic Effects of Streptolysins S and O , 1972, Infection and immunity.

[53]  I. Ginsburg,et al.  OXYGEN-STABLE HEMOLYSINS OF GROUP A STREPTOCOCCI , 1965, The Journal of experimental medicine.

[54]  I. Ginsburg,et al.  OXYGEN-STABLE HEMOLYSINS OF GROUP A STREPTOCOCCI. II. CHROMATOGRAPHIC AND ELECTROPHORETIC STUDIES. , 1963 .

[55]  S. Halbert,et al.  The analysis of streptococcal infections. V. Cardiotoxicity of streptolysin O for rabbits in vivo. , 1961 .